-
Mashup Score: 0Biomedical publisher Future Science Group joins Taylor & Francis - 3 month(s) ago
Taylor & Francis now becomes the fourth largest publisher of pharma-funded research, with the addition of 32 peer-reviewed FSG journals and five digital hubs.
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0CNS 10th Birthday - 1 year(s) ago
To celebrate CNS Oncology 10th Birthday, we are offering a 25% discount on article processing fees until the end of 2022. Submit your article today!
Source: info.future-science-group.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Celebrate Our 10th Birthday With Us🎉🎊 We are welcoming unsolicited article proposals. Make your research article the best one yet and submit your proposal today! Submit Your Article Today And Receive 25% Off Article Processing Fees: https://t.co/zf36YhFrMC https://t.co/T6KGaC43AK
-
-
Mashup Score: 0Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology Branch | CNS Oncology - 2 year(s) ago
Background: To illustrate challenges of imaging interpretation in patients with oligodendroglioma seen at a referral center and evaluate interrater reliability. Methods: Two neuro-oncologists reviewed diagnostic preradiation MRIs of oligodendroglioma patients; interrater reliability was calculated with the kappa coefficient (k). A neuroradiologist measured presurgical apparent diffusion…
Source: CNS OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #openaccess study illustrates the challenges of imaging interpretation in patients with #oligodendroglioma https://t.co/MFR8biUxzh #CNS
-
-
Mashup Score: 0Time to treatment initiation and outcomes in high-grade glioma patients in rehabilitation: a retrospective cohort study | CNS Oncology - 4 year(s) ago
Aims: To investigate wait time (WT) for chemoradiation and survival in post-op high-grade glioma (HGG) patients admitted to inpatient rehabilitation compared with those discharged home. Materials &…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this article, the authors investigate wait time (WT) for #chemoradiation and survival in post-op high-grade #glioma (HGG) patients admitted to inpatient rehabilitation compared with those discharged home. https://t.co/cA4hIXrT5c https://t.co/hCWVrU1rMP
-
-
Mashup Score: 1Ivosidenib, an IDH1 inhibitor, in a patient with recurrent, IDH1-mutant glioblastoma: a case report from a Phase I study | CNS Oncology - 4 year(s) ago
Glioblastoma is the most common and aggressive primary brain tumor. Despite standard multimodality therapy, median overall survival remains poor with a 5-year survival rate of approximately 5% in m…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this #casereport, @delaFuenteNOnc and the team @SylvesterCancer present a patient with a recurrent IDH1-mutant #glioblastoma who experienced radiographic stable disease for more than 4 years while treated with ivosidenib. https://t.co/zTKwykrLaG @AgiosPharma https://t.co/EZGLj9cuPk
-
-
Mashup Score: 0Epidemiologic and histologic characteristics of CNS lesions: a 20-year experience of a tertiary center in Lebanon | CNS Oncology - 4 year(s) ago
Aim: Report the epidemiologic and histologic characteristics of CNS lesions in the Lebanese population. Methods: We conducted a retrospective study evaluating 2025 CNS lesions diagnosed between 199…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this article, the authors report the #epidemiologic and #histologic characteristics of #CNSlesions in the Lebanese population. https://t.co/XsUZqSBzdH https://t.co/Pus9qeyAYq
-
-
Mashup Score: 1
The discovery of a new mass involving the brain or spine typically prompts referral to a neurosurgeon to consider biopsy or surgical resection. Intraoperative decision-making depends significantly …
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this review, the authors discuss the use of #ArtificialIntelligence and #machinelearning for automated histologic diagnosis of #CNStumors. https://t.co/UAvYM76GrD https://t.co/brmvNAbyZC
-
-
Mashup Score: 0Dural-based atypical teratoid/rhabdoid tumor in an adult: DNA methylation profiling as a tool for the diagnosis | CNS Oncology - 4 year(s) ago
Atypical teratoid/rhabdoid tumor (ATRT) is a malignant CNS embryonal tumor that mostly occurs in childhood, adult cases are rare. We report a case of a 23-year-old male with an extra-axial dura-bas…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This #casereport presents the case of a 23-year-old male with an extra-axial dura-based lesion in the left frontal area, previously diagnosed as #gliosarcoma, suggesting the usefulness of #DNAmethylation profiling for diagnosing challenging #CNStumors. https://t.co/BJUt6G5Cyy https://t.co/URsz1y06LN
-
-
Mashup Score: 0Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters | CNS Oncology - 4 year(s) ago
Aim: To explore fecal short-chain fatty acids and neurotransmitter alterations in a mouse–glioma model and glioma patients. Methods: Liquid chromatography–mass spectrometry and 16S rRNA-sequencing …
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this preliminary communication the authors demonstrate the interplay between #glioma and the gut–brain axis. #microbiome https://t.co/8xlC0Ggx0C https://t.co/iS2QiP08ec
-
-
Mashup Score: 0
Aim: To determine if enrollment on glioblastoma (GBM) interventional clinical trials (ICTs) in the USA is representative of the population. Materials & methods: We queried ClinicalTrials.gov for al…
Source: www.futuremedicine.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this short communication, the authors investigate the disparities in patient enrollment on #glioblastoma #clinicaltrials. https://t.co/WBakinZXIa https://t.co/EC8y9KPj7V
-
🚨 Important Announcement: CNS Oncology Jnl has been acquired by Taylor and Francis. Our Twitter account will be closing on 1st March 2024. Stay updated with Taylor&Francis News @tandfnewsroom Thank you for your support! https://t.co/lW2Jhb370A https://t.co/3bNdmxbbbm